Medivir Sells Cross Pharma to Unimedic

Medivir AB has agreed to sell Cross Pharma AB to Unimedic AB, a subsidiary of MedCap AB. The consideration is 125 MSEK on a cash and debt free basis. MedCap is a Nordic listed private equity player.

DealsNorth AmericaUSBriefs